304, E100E108
Some research suggests it may enhance GLP-1 receptor activity, but again, human evidence is preliminary
PPAR, peroxisome proliferators-activated receptors
Development of Microbial Therapeutics for Metabolic-Associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials
Clinical Studies 14.1 Overview of Clinical Trials BYDUREON has been studied in adult patients with type 2 diabetes mellitus as monotherapy and in combination with metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea, a combination of metformin and a thiazolidinedione, in combination with a SGLT2 inhibitor on a background of metformin, and in combination with basal insulin [see Clinical Studies (14.2, 14.3)]
When fiber and hydration are both inadequate, this can cause meaningful discomfort and reduce quality of life during treatment